Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The <scp>RAINBOW</scp> ‐ <scp>IBD</scp> Study of <scp>ENEIDA</scp>

In the long term, some patients with IBD need biologic escalation, which frequently recaptures durable clinical remission. De-escalation is feasible in some patients. Re-escalation is generally effective after relapse.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-08-08
DOI
https://doi.org/10.1111/apt.70312
Citations
4
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
7.27

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW ‐ IBD Study of ENEIDA

Carlos Tardillo, Gemma Valldosera, Jordi Guardiola, Fernando Gomollón et al.
4 citations
Alimentary Pharmacology & Therapeutics
Inflammatory Bowel Disease
7.27
article

Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW ‐ IBD Study of ENEIDA

Carlos Tardillo, Gemma Valldosera, Jordi Guardiola, Fernando Gomollón, Daniel Ginard, Hipólito Fernández, Manuel Van Domselaar, Mercè Navarro‐Llavat, Carlos Taxonera, Javier P. Gisbert, María José Casanova, Daniel Carpio, Pilar Varela, Cristina Rubín de Célix, Ana Fuentes Coronel, José María Huguet, Antonio Giordano, Lara Arias, Víctor Manuel Navas‐López, Pau Gilabert, Jennifer Jao, David Busquets, Rosa Ana Muñoz, Eva Iglesias, Fernando Bermejo, Míriam Mañosa, Guillermo Alcaín, Santiago García‐López, Teresa Martínez Pérez, Francisco Mesonero, Ramón Pajares, Isabel Vera, María Dolores Martin‐Arranz, María Esteve, Lucía Márquez, Ángel Ponferrada-Díaz, Patricia Ramírez de la Piscina, Xavier Calvet, Ana Gutiérrez, Pablo Vega, Elena Ricart, María Chaparro, Alfredo José Lucendo, Manuel Barreiro‐de Acosta, Pedro Almela, Rufo Lorente, Cristina Rodríguez‐Gutiérrez, Eugeni Domènech, Yolanda Ber, Marta Piqueras, Blau Camps, Luis Ignacio Fernández-Salazar, Ruth de Francisco, Laura Ramos, Iago Rodríguez–Lago, Fernando Muñoz, Santiago Frago, Federico Argüelles‐Arias, Pilar Nos, Luís Bujanda, Mónica Sierra‐Ausín, Carles Suria Bolufer, Carmen Muñoz‐Villafranca, Luis Hernández, Carolina Marlene Martínez-Flores, Luisa de Castro, Francisco Javier García‐Alonso, Montserrat Rivero, Joan Riera, Ignacio Marín-Jiménez, José Lázaro Pérez‐Calle, Pilar Robledo Andrés, Jerzy Gil, Lidia Buendía Sánchez, Mariana Fe García-Sepulcre, Eva Sesé
article en
4 citations

Abstract

In the long term, some patients with IBD need biologic escalation, which frequently recaptures durable clinical remission. De-escalation is feasible in some patients. Re-escalation is generally effective after relapse.

Alimentary Pharmacology & TherapeuticsVol. 63(1)
Universitat Autònoma de Barcelona (ES), University of the Basque Country (ES), Universidad Francisco de Vitoria (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Santa Barbara Cottage Hospital (US), Instituto de Salud Carlos III (ES), Hospital de Sant Pau (ES), Bellvitge University Hospital (ES), Hospital Universitari Arnau de Vilanova (ES), University Hospital Complex Of Vigo (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Clínico San Carlos (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital San Juan de la Cruz (ES), Hospital General De Segovia (ES), Hospital Son Llatzer (ES), Hospital Universitario Nuestra Señora de Candelaria (ES), Hospital Universitario de Torrejón (ES), Hospital Universitario Virgen Macarena (ES), Althaia (ES), Hospital Virgen de la Luz (ES), Hospital de Basurto (ES), Hospital Clínico Universitario de Valencia (ES), Complejo Hospitalario Universitario de Santiago (ES), Hospital de Viladecans (ES), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES), Consorci Sanitari de Terrassa (ES), Complejo Hospitalario de Salamanca (ES), Hospital Universitario Fundación Alcorcón (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Regional Universitario de Málaga (ES), Hospital Universitario Araba (ES), Hospital General de Tomelloso (ES), Hospital General de Granollers (ES), Hospital Infantil Universitario Niño Jesús (ES), Instituto de Investigación Marqués de Valdecilla (ES), Hospital Universitario de Burgos (ES), Hospital General Universitario de Elche (ES), Hospital General Universitario de Ciudad Real (ES), Hospital de Galdakao (ES), Navarrabiomed (ES), Hospital Universitario Reina Sofía (ES), Hospital General Universitari de Castelló (ES), Hospital General Universitario De Valencia (ES), Hospital Virgen de la Concha (ES), Mútua Terrassa (ES), Hospital Universitario de La Princesa (ES), Hospital Del Mar (ES), Hospital de Sant Joan Despí Moisès Broggi (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Clínico Universitario Lozano Blesa (ES), Instituto de Investigación Sanitaria Aragón (ES), Institute of Research and Innovation Parc Tauli (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Hospital San Pedro (ES), Complexo Hospitalario Universitario A Coruña (ES), Servicio de Salud de Castilla La Mancha (ES), Hospital Universitario de Fuenlabrada (ES), Hospital Universitario De Cabueñes (ES), Hospital Vega Baja (ES), Hospital Universitari Joan XXIII de Tarragona (ES), Hospital Universitario Son Espases (ES), Hospital Universitari Germans Trias i Pujol (ES), Hospital Universitari de Girona Doctor Josep Trueta (ES), Hospital del Mar Research Institute (ES), Hospital General San Jorge (ES), Hospital Clínico Universitario Virgen de la Victoria (ES), Universidad de Zamora (MX), Hospital Clínico Universitario de Valladolid (ES), Hospital Universitario Río Hortega (ES), Complejo Hospitalario de Pontevedra (ES), Complejo Hospitalario de Cáceres (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Hospital Universitario Infanta Sofía (ES), Hospital Universitario Ramón y Cajal (ES), Complejo Asistencial Universitario de Palencia (ES), Complejo Hospitalario de Ourense (ES), Hospital Universitario Infanta Leonor (ES), Instituto de Investigación Sanitaria del Principado de Asturias (ES), Universidad Autónoma de Madrid (ES)
Eli Lilly and Company
Good health and well-being
Openalex Percentile: Top 3%
Inflammatory Bowel Disease
7.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.